Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]
News [2438]
Articles [146]
Editorials [8]
Conferences [102]
elearning [12]
Halving duration of ADT for high risk prostate cancer patients
Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Halving duration of ADT for high risk prostate cancer patients ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
4 Jun 2017
Expert prostate discussion: Clinical diagnostics, genomics, systemic and...
Dr Chris Parker and Prof Charles Ryan
Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiological treatment ( Dr Chris Parker and Prof Charles Ryan )
4 Jun 2017
Global study sets new risk-based standard to personalise chemotherapy for colon...
Dr Axel Grothey - Mayo Clinic Cancer Centre, Rochester, USA
Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery ( Dr Axel Grothey - Mayo Clinic Cancer Centre, Rochester, USA )
4 Jun 2017
Pooled analysis of avelumab for metastatic urothelial carcinoma
Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
Pooled analysis of avelumab for metastatic urothelial carcinoma ( Dr Andrea Apolo - National Cancer Institute, Bethesda, USA )
3 Jun 2017
Delaying metastatic prostate cancer, improving survival with abiraterone
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Delaying metastatic prostate cancer, improving survival with abiraterone ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
3 Jun 2017
STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression...
Prof Nick James - Queen Elizabeth Hospital Birmingham & University of...
STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression/deaths ( Prof Nick James - Queen Elizabeth Hospital Birmingham & University of Birmingham, UK )
3 Jun 2017
Hypogonadism following cisplatin treatment of testicular cancer
Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine...
Hypogonadism following cisplatin treatment of testicular cancer ( Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis, USA )
2 Jun 2017
Low testosterone after testicular cancer could be linked to chronic health...
Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine...
Low testosterone after testicular cancer could be linked to chronic health problems ( Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis, USA )
2 Jun 2017
Editor's Choice for April 2017
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for April 2017 ( Prof Gordon McVie - Editor in Chief, ecancer )
28 Apr 2017
Projections of cancer incidence and burden among the HIV-positive population in...
Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA
Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030 ( Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA )
12 Apr 2017
Glycemia positively associated with prostate cancer mortality in non-diabetic...
Michael Marrone - Johns Hopkins University, Baltimore, USA
Glycemia positively associated with prostate cancer mortality in non-diabetic men ( Michael Marrone - Johns Hopkins University, Baltimore, USA )
12 Apr 2017
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid...
Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation